1595 related articles for article (PubMed ID: 19770543)
1. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK
Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543
[TBL] [Abstract][Full Text] [Related]
2. Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator.
Derex L; Nighoghossian N; Hermier M; Adeleine P; Berthezène Y; Philippeau F; Honnorat J; Froment JC; Trouillas P
J Neurol Sci; 2004 Oct; 225(1-2):3-9. PubMed ID: 15465079
[TBL] [Abstract][Full Text] [Related]
3. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients.
Kimura K; Iguchi Y; Shibazaki K; Kobayashi K; Uemura J; Aoki J; Yamashita S; Terasawa Y; Matsumoto N
J Neurol Sci; 2008 Jul; 270(1-2):48-52. PubMed ID: 18304581
[TBL] [Abstract][Full Text] [Related]
4. Recanalization of middle cerebral artery and intracranial aneurysm in the same ischemic territory with intravenous administration of recombinant tissue plasminogen activator: case report.
Matsuzaki T; Yoshino A; Sakatani K; Katayama Y
J Stroke Cerebrovasc Dis; 2011; 20(3):269-72. PubMed ID: 20630773
[TBL] [Abstract][Full Text] [Related]
5. MRI-based ultrafast protocol thrombolysis with rt-PA for acute ischemia stroke in 12-hour time window.
Li YH; Li MH; Zhao JG; Wang W
J Neuroimaging; 2011 Oct; 21(4):332-9. PubMed ID: 21121996
[TBL] [Abstract][Full Text] [Related]
6. Cerebral autoregulation dynamics in acute ischemic stroke after rtPA thrombolysis.
Reinhard M; Wihler C; Roth M; Harloff A; Niesen WD; Timmer J; Weiller C; Hetzel A
Cerebrovasc Dis; 2008; 26(2):147-55. PubMed ID: 18560218
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of blood pressure variability after thrombolysis in acute stroke.
Delgado-Mederos R; Ribo M; Rovira A; Rubiera M; Munuera J; Santamarina E; Delgado P; Maisterra O; Alvarez-Sabin J; Molina CA
Neurology; 2008 Aug; 71(8):552-8. PubMed ID: 18550860
[TBL] [Abstract][Full Text] [Related]
8. Recanalization of the MCA should play an important role in dramatic recovery after t-PA therapy in patients with ICA occlusion.
Kimura K; Iguchi Y; Shibazaki K; Iwanaga T; Aoki J
J Neurol Sci; 2009 Oct; 285(1-2):130-3. PubMed ID: 19573877
[TBL] [Abstract][Full Text] [Related]
9. Hemorrhagic transformation of ischemic brain tissue after t-PA thrombolysis as detected by MRI may be asymptomatic, but impair neurological recovery.
Kimura K; Iguchi Y; Shibazaki K; Aoki J; Terasawa Y
J Neurol Sci; 2008 Sep; 272(1-2):136-42. PubMed ID: 18602647
[TBL] [Abstract][Full Text] [Related]
10. Association of pretreatment ASPECTS scores with tPA-induced arterial recanalization in acute middle cerebral artery occlusion.
Tsivgoulis G; Saqqur M; Sharma VK; Lao AY; Hoover SL; Alexandrov AV;
J Neuroimaging; 2008 Jan; 18(1):56-61. PubMed ID: 18190497
[TBL] [Abstract][Full Text] [Related]
11. Buying time for recanalization in acute stroke: arterial blood infusion beyond the occluding clot as a neuroprotective strategy.
Ribó M; Molina C; Alvarez B; Dinia L; Alvarez-Sabin J; Matas M
J Neuroimaging; 2009 Apr; 19(2):188-90. PubMed ID: 18800999
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy of moderate hypothermia and thrombolysis in experimental thromboembolic stroke--an MRI study.
Kollmar R; Henninger N; Bardutzky J; Schellinger PD; Schäbitz WR; Schwab S
Exp Neurol; 2004 Nov; 190(1):204-12. PubMed ID: 15473993
[TBL] [Abstract][Full Text] [Related]
13. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
[TBL] [Abstract][Full Text] [Related]
14. Recanalization within one hour after intravenous tissue plasminogen activator is associated with favorable outcome in acute stroke patients.
Kimura K; Iguchi Y; Shibazaki K; Aoki J; Watanabe M; Kobayashi K; Sakamoto Y
Eur Neurol; 2010; 63(6):331-6. PubMed ID: 20516694
[TBL] [Abstract][Full Text] [Related]
15. Three cases of middle cerebral artery occlusion emergently revascularized with a balloon-expandable coronary bare stent after intravenous tissue plasminogen activator.
Fukuoka T; Dembo T; Nagoya H; Deguchi I; Maruyama H; Kanazawa R; Kohyama S; Yamane F; Ishihara S; Tanahashi N
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):883-9. PubMed ID: 21767964
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat.
Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Divine GW; Chopp M
J Cereb Blood Flow Metab; 1998 Jul; 18(7):758-67. PubMed ID: 9663506
[TBL] [Abstract][Full Text] [Related]
17. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.
Mathews MS; Sharma J; Snyder KV; Natarajan SK; Siddiqui AH; Hopkins LN; Levy EI
Neurosurgery; 2009 Nov; 65(5):860-5; discussion 865. PubMed ID: 19834397
[TBL] [Abstract][Full Text] [Related]
18. [Prospects of thrombolytic therapy for acute ischemic stroke].
Nakashima T; Minematsu K
Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of MRI-based selection for recombinant tissue plasminogen activator treatment: responder analysis of outcome in the 3-hour time window.
Sølling C; Hjort N; Ashkanian M; Østergaard L; Andersen G
Cerebrovasc Dis; 2009; 27(3):223-9. PubMed ID: 19176954
[TBL] [Abstract][Full Text] [Related]
20. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
